6.
Islam M, Ali S, Karmoker J, Kadir M, Ahmed M, Nahar Z
. Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder. BMC Psychiatry. 2020; 20(1):333.
PMC: 7315550.
DOI: 10.1186/s12888-020-02738-2.
View
7.
Porto C, Fichman H, Caramelli P, Bahia V, Nitrini R
. Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzheimer's disease. Arq Neuropsiquiatr. 2003; 61(2B):339-45.
DOI: 10.1590/s0004-282x2003000300004.
View
8.
Shulman K
. Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry. 2000; 15(6):548-61.
DOI: 10.1002/1099-1166(200006)15:6<548::aid-gps242>3.0.co;2-u.
View
9.
Malloy-Diniz L, Lasmar V, Gazinelli L, Fuentes D, Salgado J
. The Rey Auditory-Verbal Learning Test: applicability for the Brazilian elderly population. Braz J Psychiatry. 2007; 29(4):324-9.
DOI: 10.1590/s1516-44462006005000053.
View
10.
Zhao X, Cao F, Liu Q, Li X, Xu G, Liu G
. Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression. Behav Brain Res. 2017; 364:494-502.
DOI: 10.1016/j.bbr.2017.05.064.
View
11.
Kraus C, Kadriu B, Lanzenberger R, Zarate Jr C, Kasper S
. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 2019; 9(1):127.
PMC: 6447556.
DOI: 10.1038/s41398-019-0460-3.
View
12.
Huang T, Lee C
. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci. 2007; 61(4):415-20.
DOI: 10.1111/j.1440-1819.2007.01686.x.
View
13.
Charlton R, Lamar M, Zhang A, Ren X, Ajilore O, Pandey G
. Associations between pro-inflammatory cytokines, learning, and memory in late-life depression and healthy aging. Int J Geriatr Psychiatry. 2017; 33(1):104-112.
PMC: 7297321.
DOI: 10.1002/gps.4686.
View
14.
Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E
. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57.
View
15.
Pfeffer R, Kurosaki T, Harrah Jr C, Chance J, Filos S
. Measurement of functional activities in older adults in the community. J Gerontol. 1982; 37(3):323-9.
DOI: 10.1093/geronj/37.3.323.
View
16.
Haapakoski R, Mathieu J, Ebmeier K, Alenius H, Kivimaki M
. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015; 49:206-15.
PMC: 4566946.
DOI: 10.1016/j.bbi.2015.06.001.
View
17.
Bugge E, Wynn R, Mollnes T, Reitan S, Gronli O
. Cytokine profiles and diagnoses in elderly, hospitalized psychiatric patients. BMC Psychiatry. 2018; 18(1):315.
PMC: 6161441.
DOI: 10.1186/s12888-018-1900-y.
View
18.
Rahman S, Shanta A, Daria S, Nahar Z, Shahriar M, Qusar M
. Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study. PLoS One. 2022; 17(2):e0264404.
PMC: 8880862.
DOI: 10.1371/journal.pone.0264404.
View
19.
Kim Y, Na K, Shin K, Jung H, Choi S, Kim J
. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(5):1044-53.
DOI: 10.1016/j.pnpbp.2007.03.004.
View
20.
Moulton C, Pickup J, Ismail K
. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015; 3(6):461-471.
DOI: 10.1016/S2213-8587(15)00134-5.
View